A Agilent Technologies Inc.

Agilent Launches New Advanced Dilution System to Increase Lab Efficiency

Agilent Technologies Inc. (NYSE: A) today announced the launch of the , the ADS 2, a new automation workflow solution that will increase productivity, lower cost of ownership, and improve the overall efficiency within the laboratory.

The Agilent ADS 2 is an intelligent autodilutor designed to enhance laboratory workflows. Designed to integrate seamlessly with Agilent autosamplers, ICP-OES and ICP-MS instruments and software, it offers a fully integrated, single-supplier automated solution.

As one of the most trusted brands in the analytical instrumentation market, Agilent worked with a wide range of customers to address key barriers to autodilution adoption. The result is an easy to install, highly efficient and robust solution for production environments, utilizing unique flow path technology to optimize the speed of analysis for both diluted and undiluted samples, and the same software as the instrument to ensure consistency and traceability in data handling and reporting.

“We understand that the ability to enhance lab productivity without compromising quality or profitability is of utmost importance to our customers,” stated Keith Bratchford, vice president and general manager of Agilent's Atomic Spectroscopy Division. “Agilent’s comprehensive automation system establishes us as the exclusive provider capable of meeting the needs of routine food, environmental, and pharmaceutical testing laboratories. Furthermore, the ADS 2 will have significant applications in the advanced materials market, particularly in battery research, differentiating us from our competitors.”

Agilent’s single-vendor approach offers a seamless and attractive alternative for our valued customers, resulting in simplified data management, and increased productivity.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at . To receive the latest Agilent news, please subscribe to the Agilent . Follow Agilent on and .

EN
01/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

 PRESS RELEASE

Agilent to Participate in Jefferies Global Healthcare Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced that CFO Bob McMahon will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City on Wednesday, June 5, at 8:30 a.m. EDT. Those interested in listening to the live or recorded session can access it from the . The recording will be available for 90 days. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great scienc...

 PRESS RELEASE

Agilent Presents Solutions Innovation Research Awards to Cornell and I...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced two Solutions Innovation Research Awards (SIRA) presented to Professors and . These separate awards recognize their outstanding contributions to advanced materials research. Electrocatalysis plays a pivotal role in advancing clean energy systems. Enhancing the efficiency of chemical reactions at electrode surfaces can accelerate the transition to sustainable energy sources. High-entropy nanoparticles—materials that incorporate many different types of atoms into one lattice—offer a fresh perspective in electrocatalysis. Their ...

 PRESS RELEASE

Agilent to Announce Second-Quarter Fiscal Year 2024 Financial Results ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) will release financial results for the second quarter of fiscal year 2024 after the stock market closes on May 29. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PT. To join the listen-only conference call webcast, click the link on the of Agilent’s investor relations website. A recording of the call will also be available on the website for 90 days. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory tec...

 PRESS RELEASE

Padraig McDonnell Assumes Agilent CEO Role

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE:A) today announced that Padraig McDonnell has assumed the role of Agilent CEO, effective immediately. His appointment is part of the company’s CEO . McDonnell is the fourth CEO in Agilent’s history and succeeds Mike McMullen, who will serve as an adviser until he retires Oct. 31. This press release features multimedia. View the full release here: Padraig McDonnell (Photo: Business Wire) “It’s an incredible honor to serve as CEO of this great company that impacts the world by advancing the quality of life,” McDonnell said. ...

 PRESS RELEASE

Agilent Announces the NovoCyte Opteon, a Cutting-Edge Spectral Flow Cy...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility. This cutting-edge system sets a gold standard for acquiring, analyzing, and reporting flow data across diverse domains—from basic research to drug discovery and therapy development. The NovoCyte Opteon represents a significant leap forward in flow cytometry technology, with configurations ranging from three to five lasers and support for up to 73 high-quality detectors. It meets researchers’ needs for sophisticated, large-...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch